| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A bispecific approach to improving CAR T cells in AML
|
Daver, Naval
|
|
|
135 |
10 |
p. 703-704
|
artikel
|
| 2 |
Bispecific and split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid leukemia
|
He, Xin
|
|
|
135 |
10 |
p. 713-723
|
artikel
|
| 3 |
Breaking through BCL-2 inhibition in CLL
|
Chong, Stephen J.F.
|
|
|
135 |
10 |
p. 709-711
|
artikel
|
| 4 |
Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study
|
Straus, David J.
|
|
|
135 |
10 |
p. 735-742
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
135 |
10 |
p. i
|
artikel
|
| 6 |
Fc-modified HIT-like monoclonal antibody as a novel treatment for sepsis
|
Gollomp, Kandace
|
|
|
135 |
10 |
p. 743-754
|
artikel
|
| 7 |
Hemophagocytic lymphohistiocytosis secondary to babesiosis
|
Dermawan, Josephine Kamtai
|
|
|
135 |
10 |
p. 779
|
artikel
|
| 8 |
“HIT”ing back against NETs
|
Swaidani, Shadi
|
|
|
135 |
10 |
p. 706-707
|
artikel
|
| 9 |
How I assess and manage the risk of bleeding in patients treated for venous thromboembolism
|
Klok, Frederikus A.
|
|
|
135 |
10 |
p. 724-734
|
artikel
|
| 10 |
Molecular monitoring during dose reduction predicts recurrence after TKI cessation in CML
|
Gottschalk, Andrea
|
|
|
135 |
10 |
p. 766-769
|
artikel
|
| 11 |
Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax
|
Blombery, Piers
|
|
|
135 |
10 |
p. 773-777
|
artikel
|
| 12 |
Niemann-Pick disease with isolated leukemic nonnodal mantle cell lymphoma of the spleen
|
Fu, Chieh Lin
|
|
|
135 |
10 |
p. 778
|
artikel
|
| 13 |
Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous disease
|
Melchers, Rutger C.
|
|
|
135 |
10 |
p. 769-773
|
artikel
|
| 14 |
Rank CU, Toft N, Tuckuviene R, et al. Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years. Blood. 2018;131(22):2475-2484.
|
|
|
|
135 |
10 |
p. 780
|
artikel
|
| 15 |
Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways
|
Noubouossie, Denis F.
|
|
|
135 |
10 |
p. 755-765
|
artikel
|
| 16 |
The efficacy-toxicity conundrum: breaking the mold
|
Diehl, Louis F.
|
|
|
135 |
10 |
p. 704-706
|
artikel
|
| 17 |
Thromboinflammatory effects of RBC microvesicles
|
Stavrou, Evi X.
|
|
|
135 |
10 |
p. 708-709
|
artikel
|
Tijdschrift beschrijving